Search
Descriptor English: Nafronyl
Descriptor Spanish: Nafronil
Descriptor nafronil
Entry term(s) nafroniloxalato
naftidrofurilo
Scope note: Fármaco utilizado en el control de enfermedades vasculares periféricas y cerebrales. Se considera que aumenta la capacidad oxidativa celular y que es espasmolítico (Martindale, The Extra Pharmacopoeia, 30th ed, p1310). También puede actuar como antagonista de los receptores 5HT-2 de serotonina.
Descriptor Portuguese: Nafronil
Descriptor French: Naftidrofuryl
Entry term(s): Artocoron
Azunaftil
Di Actane
Di-Actane
Dusodril
Gévatran
LS 121
LS-121
LS121
Nafronyl Oxalate
Nafronyloxalate
Nafti Puren
Nafti Ratiopharm
Nafti Von Ct
Nafti-Puren
Nafti-Ratiopharm
NaftiRatiopharm
Naftidrofuryl
Naftifurin Oxalate
Naftilong
Naftilux
Oxalate, Nafronyl
Oxalate, Naftifurin
Praxilene
Praxilène
Tree number(s): D03.383.312.620
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D009257
Scope note: A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1310) It may also be an antagonist at 5HT-2 serotonin receptors.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Serotonin Antagonists
Vasodilator Agents
Registry Number: 42H8PQ0NMJ
CAS Type 1 Name: 2-Furanpropanoic acid, tetrahydro-alpha-(1-naphthalenylmethyl)-, 2-(diethylamino)ethyl ester
Previous Indexing: Diethylamines (1974)
Furans (1971-1974)
Naphthalenes (1971-1974)
Propionates (1971-1974)
Public MeSH Note: 91; was see under FURANS 1975-90
History Note: 91(75); was see under FURANS 1975-90
DeCS ID: 9448
Unique ID: D009257
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1991/01/01
Date of Entry: 1974/11/19
Revision Date: 2017/05/24
Nafronyl - Preferred
Concept UI M0014423
Scope note A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1310) It may also be an antagonist at 5HT-2 serotonin receptors.
Preferred term Nafronyl
Entry term(s) Naftidrofuryl
Azunaftil - Narrower
Concept UI M0462785
Preferred term Azunaftil
Di-Actane - Narrower
Concept UI M0462786
Preferred term Di-Actane
Entry term(s) Di Actane
Dusodril - Narrower
Concept UI M0353183
Preferred term Dusodril
Gévatran - Narrower
Concept UI M0462783
Preferred term Gévatran
Praxilene - Narrower
Concept UI M0014425
Preferred term Praxilene
Entry term(s) Praxilène
Nafronyloxalate - Narrower
Concept UI M0014424
Preferred term Nafronyloxalate
Entry term(s) Nafronyl Oxalate
Naftifurin Oxalate
Oxalate, Nafronyl
Oxalate, Naftifurin
Nafti Von Ct - Narrower
Concept UI M0462787
Preferred term Nafti Von Ct
Nafti-Puren - Narrower
Concept UI M0462788
Preferred term Nafti-Puren
Entry term(s) Nafti Puren
Nafti-Ratiopharm - Narrower
Concept UI M0462789
Preferred term Nafti-Ratiopharm
Entry term(s) Nafti Ratiopharm
NaftiRatiopharm
Naftilong - Narrower
Concept UI M0462790
Preferred term Naftilong
Naftilux - Narrower
Concept UI M0462791
Preferred term Naftilux
Artocoron - Narrower
Concept UI M0462784
Preferred term Artocoron
LS-121 - Narrower
Concept UI M0353182
Preferred term LS-121
Entry term(s) LS 121
LS121



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey